Search Results

Effects of Peptidic Antagonists of Grb2-SH2 on Human Breast Cancer Cells

Authors: Chen, Chiu-Heng; Chen, Meng-Kai; Jeng, Kee-Ching G.; Lung, Feng-Di T.

Source: Protein and Peptide Letters, Volume 17, Number 1, January 2010 , pp. 44-53(10)

Publisher: Bentham Science Publishers

The Role of Apoptosis in Cancer Development and Treatment: Focusing on the Development and Treatment of Hematologic Malignancies

Authors: Zivny, J.; Klener jr., P.; Pytlik, R.; Andera, L.

Source: Current Pharmaceutical Design, Volume 16, Number 1, January 2010 , pp. 11-33(23)

Publisher: Bentham Science Publishers

Targeting AAC-11 in cancer therapy

Authors: Faye, Audrey; Poyet, Jean-Luc

Source: Expert Opinion on Therapeutic Targets, Volume 14, Number 1, January 2010 , pp. 57-65(9)

Publisher: Informa Healthcare

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-1 and receptor-2 agonists for cancer therapy

Authors: Fox, Norma Lynn; Humphreys, Robin; Luster, Troy A; Klein, Jerry; Gallant, Gilles

Source: Expert Opinion on Biological Therapy, Volume 10, Number 1, January 2010 , pp. 1-18(18)

Publisher: Informa Healthcare

Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy

Authors: Liu, X.; Newton, R. C.; Friedman, S. M.; Scherle, P. A.

Source: Current Cancer Drug Targets, Volume 9, Number 8, December 2009 , pp. 938-952(15)

Publisher: Bentham Science Publishers

Epigenetic Therapy: Histone Acetylation, DNA Methylation and Anti-Cancer Drug Discovery

Authors: Ganesan, A.; Nolan, L.; Crabb, S. J.; Packham, G.

Source: Current Cancer Drug Targets, Volume 9, Number 8, December 2009 , pp. 963-981(19)

Publisher: Bentham Science Publishers

Cutting the Limits of Aminobisphosphonates: New Strategies for the Potentiation of their Anti-Tumour Effects

Authors: Marra, M.; Abbruzzese, A.; Addeo, R.; Prete, S. D.; Tassone, P.; Tonini, G.; Tagliaferri, P.; Santini, D.; Caraglia, M.

Source: Current Cancer Drug Targets, Volume 9, Number 7, November 2009 , pp. 791-800(10)

Publisher: Bentham Science Publishers

Anti-Tumour Effects of Bisphosphonates - What have we Learned from In Vivo Models?

Authors: Brown, H. K.; Holen, I.

Source: Current Cancer Drug Targets, Volume 9, Number 7, November 2009 , pp. 807-823(17)

Publisher: Bentham Science Publishers

Anti-angiogenic Therapy Against Gastrointestinal Tract Cancers

Authors: Iwasaki, Junko; Nihira, Shin-ichi

Source: Japanese Journal of Clinical Oncology, Volume 39, Number 9, 11 September 2009 , pp. 543-551(9)

Publisher: Oxford University Press

Alternate Strategies of Hsp90 Modulation for the Treatment of Cancer and Other Diseases

Authors: Brandt, Gary E.L.; Blagg, Brian S.J.

Source: Current Topics in Medicinal Chemistry, Volume 9, Number 15, November 2009 , pp. 1447-1461(15)

Publisher: Bentham Science Publishers

Recent Research in Selective Cyclin-Dependent Kinase 4 Inhibitors for Anti-Cancer Treatment

Authors: Liu, Ning; Fang, Hao; Li, Yanling; Xu, Wenfang

Source: Current Medicinal Chemistry, Volume 16, Number 36, December 2009 , pp. 4869-4888(20)

Publisher: Bentham Science Publishers

HIF-1 Inhibitors for Cancer Therapy: From Gene Expression to Drug Discovery

Author: Semenza, G. L.

Source: Current Pharmaceutical Design, Volume 15, Number 33, November 2009 , pp. 3839-3843(5)

Publisher: Bentham Science Publishers

The hepoxilins and some analogues: a review of their biology

Author: Pace-Asciak, Cecil R

Source: British Journal of Pharmacology, Volume 158, Number 4, October 2009 , pp. 972-981(10)

Publisher: Blackwell Publishing

Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties

Authors: Hegedűs, C; Özvegy-Laczka, C; Apáti, Á; Magócsi, M; Német, K; Őrfi, L; Kéri, G; Katona, M; Takáts, Z; Váradi, A; Szakács, G; Sarkadi, B

Source: British Journal of Pharmacology, Volume 158, Number 4, October 2009 , pp. 1153-1164(12)

Publisher: Blackwell Publishing

Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients

Authors: Ghayad, Sandra E.; Cohen, Pascale A.

Source: Recent Patents on Anti-Cancer Drug Discovery, Volume 5, Number 1, January 2010 , pp. 29-57(29)

Publisher: Bentham Science Publishers

Patent Selections

Author: Bentham Science Publishers,

Source: Recent Patents on Anti-Cancer Drug Discovery, Volume 5, Number 1, January 2010 , pp. 84-87(4)

Publisher: Bentham Science Publishers

Targeted delivery of an anti-cancer agent via steroid coupled liposomes

Authors: Mishra, Pramod K.; Gulbake, Arvind; Jain, Aviral; Vyas, Suresh P.; Jain, Sanjay K

Source: Drug Delivery, Volume 16, Number 8, November 2009 , pp. 437-447(11)

Publisher: Informa Healthcare

Anti-Angiogenic Cancer Therapy Updates

Authors: Ali, A. M.; Toi, M.; Ueno, T.

Source: Current Molecular Medicine, Volume 9, Number 8, November 2009 , pp. 954-966(13)

Publisher: Bentham Science Publishers

Editorial [Hot topic: Prostate Cancer Therapy (Guest Editors: N. Sharifi and J.B. Aragon-Ching)]

Authors: Sharifi, N.; Aragon-Ching, J. B.

Source: Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry, Volume 9, Number 10, December 2009 , pp. 1039-1039(1)

Publisher: Bentham Science Publishers

Ecology-based screen identifies new metabolites from a Cordyceps-colonizing fungus as cancer cell proliferation inhibitors and apoptosis inducers

Authors: Chen, Y.; Guo, H.; Du, Z.; Liu, X.-Z.; Che, Y.; Ye, X.

Source: Cell Proliferation, Volume 42, Number 6, December 2009 , pp. 838-847(10)

Publisher: Blackwell Publishing